Peter Schröder

Title: Peter Schröder: Innovator in Cancer Treatment

Introduction

Peter Schröder is a notable inventor based in Dortmund, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Peter Schröder holds a patent for "Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer." This invention relates to compounds of the general formula (I), which are designed for use as medicaments in cancer therapy. The patent outlines processes for preparing these compounds, as well as their potential applications in treating cancer, either alone or in combination with other therapies. He has 1 patent to his name, reflecting his commitment to advancing medical science.

Career Highlights

Peter Schröder is associated with Lead Discovery Center GmbH, where he collaborates with other talented professionals in the field. His work focuses on the discovery and development of new therapeutic agents, particularly those that can combat cancer effectively. His innovative approach and dedication to research have positioned him as a key figure in his organization.

Collaborations

Peter has worked alongside esteemed colleagues such as Raffaella Di Lucrezia and Tim Bergbrede. These collaborations have fostered a dynamic research environment, allowing for the exchange of ideas and expertise that enhance the development of new treatments.

Conclusion

Peter Schröder's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Lead Discovery Center GmbH and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.